Advancing Diversity, Equity and Inclusion in IBD Award

Applications are accepted on a rolling basis, so we encourage you to submit nominations as early as possible.

The deadline for nominations has now been extended from July 15 by 5:00 pm ET to July 29, 5:00 pm ET. 

Award description: This award is designed to honor an individual whose clinical practice or research aligns with the mission of Crohn's Colitis Canada and is dedicated to addressing or gaining insights into matters concerning diversity, equity, and inclusion (DEI) in the context of IBD. The recipient will be granted $20,000 to bolster their clinical initiatives or research endeavors.

Prize amount: $20,000 (For investment in the recipient’s research program) The recipient of this award will have their travel, accommodation and conference fees paid to attend the Meeting of the Minds conference in Toronto, ON. They will be recognized at the Meeting of the Minds conference and have an opportunity to present their work.

Eligibility: Researcher or clinician from the DEI community; or researcher conducting research in DEI or clinician serving the DEI community

How to apply:

  1. Complete the nomination form
  2. Attach a letter of support from the nominating applicant, the nominee’s department head, or an IBD colleague
  3. Attach a CV highlighting the nominee’s accomplishments as it pertains to this award
  4. Nomination criteria: Self-nominations and nominations by IBD colleagues will be accepted.

Selection criteria: Nominations will be evaluated for demonstrated innovation and leadership in the field of IBD research in Canada as well as commitment to the mission of Crohn’s and Colitis Canada. The recipient will be selected by a Selection Panel comprised of individuals from the following groups, at the discretion of Crohn’s and Colitis Canada, and as appropriate:

  • Crohn’s and Colitis Canada Scientific and Medical Advisory Council;
  • Canadian Community of Practice of IBD Nurses (CANIBD) members;
  • Crohn’s and Colitis Canada IBD patient volunteers;
  • Crohn’s and Colitis Canada staff; or
  • Other individuals as deemed necessary by Crohn’s and Colitis Canada

Evaluation guidelines (Based on applicant responses, letter of support, and nominee CV):

  • Evidence of positively impacting the IBD community and/or patient care in Canada
  • Potential for future impact on IBD research, quality of care, and/or policies in Canada
  • Contribution to the mission and values of Crohn’s and Colitis Canada
  • Quality of recommendation from letter of support

Letter of Support guidelines: 

  • Within your letter of support, we encourage you to emphasize how the nominee's research or clinical care practice aligns with our mission to advance diversity, equity, and inclusion within the IBD field. 

Nomination form

The name of the individual you are nominating
Your name
Max 250 words
Max 250 words
Files must be below 10 MB in size
Files must be below 10 MB in size
Enter security code:
 Security code

Contact information

If you have any questions about Crohn's and Colitis Canada grant programs or award, please do not hesitate to connect with us. Direct your questions to:

Research Grants Administrator
Email: research...crohnsandcolitis...ca 

Sponsored by

Pfizer.png
Crohn's and Colitis Canada logo

  • Canada has among the highest incidence rates of Crohn's and colitis in the world.
  • 1 in 140 Canadians lives with Crohn’s or colitis.
  • Families new to Canada are developing these diseases for the first time.
  • Incidence of Crohn’s in Canadian kids under 10 has doubled since 1995.
  • People are most commonly diagnosed before age 30.

Other Areas of Interest